VerImmune

Germantown, MD · Founded 2019 · Privately Held (backing)

Developer of a virus-inspired therapeutic delivery platform designed to leverage the natural geometric structure of viruses for targeted payload transport. VerImmune is based in Germantown, MD and was founded in 2019. It was valued at $30 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $10 million across 2 recorded rounds; the latest was a $4.5 million seed round in Aug 2024.

PMV mark · valuation
$30.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$10.0M
Last round
Seed Round
Aug 2024
What is VerImmune worth?
$30.0MPrivateMarketView mark · Oct 2026

Valued at $30.0M at its later-stage round, Jul 2025. Nothing has traded since.

Free account
More of VerImmune with a free account
  • ·The complete investor list: 12 names
  • ·Watch VerImmune: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

VerImmune funding history

2 rounds
DateRoundRaisedPost-money
Aug 2024Seed Round$4.5M▮
Mar 2022Seed Round$1.4M▮
Unlock post-money valuations

Membership and data by Private Market View

VerImmune valuation

VerImmune was valued at $30 million at its later-stage round in Jul 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has VerImmune raised?

VerImmune has raised $10 million in total; 2 of its rounds are on record. The largest on record was a $4.5 million seed round in Aug 2024.

VerImmune has filed 2 Form Ds with the SEC since 2022, most recently in Sep 2024 ($4.5 million sold to 6 investors).

How VerImmune's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For VerImmune, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about VerImmune

What is VerImmune worth?
VerImmune is valued at $30.0M as of Oct 2026. Valued at $30.0M at its later-stage round, Jul 2025. Nothing has traded since.
How much has VerImmune raised?
VerImmune has raised $10.0M in total funding across 2 recorded rounds.
When did VerImmune last raise?
VerImmune last raised in Aug 2024 (Seed Round), raising $4.5M.